Title:
【発明の名称】CNS障害を治療するための組合せられたドーパミンD2、5-HT1Aおよびαアドレノレセプターアゴニスト作用、を有する化合物の使用
Document Type and Number:
Japanese Patent JP2003532676
Kind Code:
A
Abstract:
The invention relates to the use of compounds having combined sopamine D2 agonistic activity, 5-HT1A agonistic activity and a adrenoceptor agonistic activity for the treatment of CNS disorders such as Parkinson's disease.
Inventors:
Van der Haden, Johannes A.M.
Long, Stephen Kay
Fernstra, Rolov Davryeu
Van Schialenburg, Gustav J.A.M.
Long, Stephen Kay
Fernstra, Rolov Davryeu
Van Schialenburg, Gustav J.A.M.
Application Number:
JP2001581822A
Publication Date:
November 05, 2003
Filing Date:
May 10, 2001
Export Citation:
Assignee:
Solvay Pharmaceuticals B.V.
International Classes:
A61K31/00; A61K31/4184; A61K31/423; A61K31/428; A61K45/00; A61K45/06; A61P25/00; A61P25/14; C07D413/12; A61P25/16; A61P25/28; A61P43/00; (IPC1-7): A61K45/00; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P43/00; C07D413/12
Attorney, Agent or Firm:
Heiyoshi Odashima